How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Utah investigator identifies Tyler Robinson as suspect in Charlie Kirk A Utah state investigator on Monday identified Tyler Robinson in court as the suspect who video evidence showed was on a ...
Some people want to use a small screen, and some people like to use a multiple monitor setup to do every single task including viewing videos. If you have multiple monitors for everyday use, this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results